Profenid contains ketoprofen, a nonsteroidal anti-inflammatory agent with analgesic and antipyretic properties, and is registered in 26 countries spanning Europe, Latin America, the Middle East, and parts of Asia. The brand sits in the mid-range of international footprints — broad enough that travellers regularly encounter it across several continents, but not as ubiquitous as the largest global analgesic brands.
Ketoprofen is prescribed for the management of pain and inflammation in a range of clinical situations, including post-surgical pain, general pain relief, arthritis and osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, back pain, and bursitis. Some markets also register topical formulations of ketoprofen for joint and muscular pain. The structured indication block further down this page lists the registered uses recognised by national regulators in the countries where Profenid is sold.
Representative markets where Profenid carries marketing authorisation include Brazil, France, Indonesia, Lebanon, and Chile — a spread that reflects the drug's long-standing presence in both European and Latin American formularies. Travellers and expatriates moving between these regions may encounter ketoprofen under the Profenid name in one country and under a different brand or as a generic in another, since the same molecule circulates worldwide under a variety of commercial labels.
Other medications in the nonsteroidal anti-inflammatory class are widely available internationally under different active ingredients, and a local pharmacist familiar with the regional formulary can identify what is appropriate in a given market. As with any anti-inflammatory therapy, decisions about starting Profenid, substituting it for another product, or continuing it abroad belong with a qualified healthcare provider who knows the patient's history.
